In the last trading session, 15.92 million Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) shares changed hands as the company’s beta touched 1.08. With the company’s per share price at $1.69 changed hands at $0.22 or 14.97% during last session, the market valuation stood at $0.98M. BDRX’s last price was a discount, traded about -4278.7% off its 52-week high of $74.00. The share price had its 52-week low at $1.14, which suggests the last value was 32.54% up since then. When we look at Biodexa Pharmaceuticals Plc ADR’s average trading volume, we note the 10-day average is 1.81 million shares, with the 3-month average coming to 1.56 million.
Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) trade information
Instantly BDRX was in green as seen at the end of in last trading. With action 37.40%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -58.27%, with the 5-day performance at 37.40% in the green. However, in the 30-day time frame, Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) is -45.66% down. Looking at the short shares, we see there were 62096.0 shares sold at short interest cover period of 0.04 days.
Biodexa Pharmaceuticals Plc ADR (BDRX) estimates and forecasts
Year-over-year growth is forecast to reach -100.00% down from the last financial year.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 86.34%. The 2025 estimates are for Biodexa Pharmaceuticals Plc ADR earnings to increase by 99.87%, but the outlook for the next 5-year period is at 89.98% per year.
BDRX Dividends
Biodexa Pharmaceuticals Plc ADR is expected to release its next quarterly earnings report in May.
Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 8.82% of Biodexa Pharmaceuticals Plc ADR shares while 29.86% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 32.75%.
